Article Details
Retrieved on: 2024-10-24 20:52:47
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Medtronic's CE mark approval for the Evolut FX+ TAVR system, relevant to MedTech innovations in cardiac surgery, specifically aortic valve replacement. It highlights enhanced design features improving coronary access and applicability across risk categories.
Article found on: www.massdevice.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here